Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Katrin Proebstel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Muscle & Nerve|March 22, 2016
Nerve Hypertrophy in Primary AmyloidosisMaria Rasenack, Anne-Katrin Proebstel, Ioanna M Athanasopoulou, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
Acknowledgment to ReviewersScott S Zamvil, Anne-Katrin Proebstel, Marinos C Dalakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
Neurology|May 15, 2025
Factors Associated With Relapse in Patients With NeurosarcoidosisLouisa Nitsch, Dirk Skowasch, Edouard Courtin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple SclerosisJohannes Raffael Dahl, Alicia Weier, Christopher Winter, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Muscle & Nerve|March 22, 2016
Nerve Hypertrophy in Primary AmyloidosisMaria Rasenack, Anne-Katrin Proebstel, Ioanna M Athanasopoulou, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 5, 2025
Acknowledgment to ReviewersScott S Zamvil, Anne-Katrin Proebstel, Marinos C Dalakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
Neurology|May 15, 2025
Factors Associated With Relapse in Patients With NeurosarcoidosisLouisa Nitsch, Dirk Skowasch, Edouard Courtin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2025
Modulator of VRAC Current 1 Is a Potential Target Antigen in Multiple SclerosisJohannes Raffael Dahl, Alicia Weier, Christopher Winter, et al.
Brain : a Journal of Neurology|December 14, 2022
Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsRosa Cortese, Marco Battaglini, Ferran Prados, et al.
Pageof 1